Estetrol negative in Ames, mouse lymphoma, rat micronucleus and rat Comet assays (weight of evidence)
“Weight of evidence indicates that E4 is not considered genotoxic in a full battery of in vitro and in vivo assays (Ames assay, in vitro mouse lymphoma assay, an in vivo rat micronucleus assay, and in vivo rat Comet assay).”
✓ VerifiedFDA multi-discipline review, p. 37Source ↗
Carcinogenicity
Estetrol 104-week female rat: increased mammary neoplasms at 0.7x MRHD
“E4 doses of up to 0.8 mg/kg/day were administered orally to female rats for 104 weeks. At the high-dose of 0.8 mg/kg/day E4 (0.7x the MRHD on an AUC basis), there was an increased incidence of mammary neoplasms”
✓ VerifiedFDA multi-discipline review, p. 37Source ↗
Reproductive & developmental
Rat and rabbit EFD: fetal growth retardation and developmental effects secondary to maternal toxicity; no intrinsic teratogenicity
“The observed fetal growth retardation and developmental effects were likely consequences of maternal toxicity in the pregnant female rat and rabbit. There are no indications for intrinsic teratogenic properties of E4 or DRSP in either rat or rabbit.”
✓ VerifiedFDA multi-discipline review, p. 39Source ↗
Safety pharmacology
No cardiovascular effects in telemetered monkeys and no respiratory effects in rats at ≥115x MRHD
“E4 did not alter the cardiovascular function of telemetered monkeys and did not affect the respiratory functions of rats up to the highest dose tested (100 mg/kg in monkeys and 150 mg/kg in rats), with safety margins of approximately 115 times and 830 times the MRHD on an AUC basis, respectively.”
✓ VerifiedFDA multi-discipline review, p. 35Source ↗
Not genotoxic overall: Ames negative; in vitro chromosome aberration positive without (not with) metabolic activation; rat micronucleus and comet negative